Literature DB >> 1243126

A new central direct dopaminergic stimulant: 1-(Coumaran-5-yl methyl)-4-(2-thiazolyl) piperazine hydrochloride (S 3608).

J C Poignant, H Gressier, M Petitjean, G Regnier, R Canevari.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1243126     DOI: 10.1007/bf02326795

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  10 in total

1.  Evidence for a new type of dopamine receptor stimulating agent.

Authors:  H Corrodi; K Fuxe; U Ungerstedt
Journal:  J Pharm Pharmacol       Date:  1971-12       Impact factor: 3.765

2.  The site and mode of action of ET495 for the mediation of stereotyped behaviour in the rat.

Authors:  B Costall; R J Naylor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

3.  ET495 and brain catecholamine mechanisms: evidence for stimulation of dopamine receptors.

Authors:  H Corrodi; L O Farnebo; K Fuxe; B Hamberger; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1972-11       Impact factor: 4.432

4.  Synthesis and vasodilator activity of new piperazine derivatives.

Authors:  G L Regnier; R J Canevari; M J Laubie; J C Le Douarec
Journal:  J Med Chem       Date:  1968-11       Impact factor: 7.446

5.  Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats.

Authors:  A M Ernst
Journal:  Psychopharmacologia       Date:  1967

6.  Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

Authors:  U Ungerstedt; G W Arbuthnott
Journal:  Brain Res       Date:  1970-12-18       Impact factor: 3.252

7.  Letter: Preliminary investigation of the metabolism of piribedil (ET 495); a new central dopaminergic agonist and potential anti-parkinson agent.

Authors:  P Jenner; A R Taylor; D B Campbell
Journal:  J Pharm Pharmacol       Date:  1973-09       Impact factor: 3.765

8.  Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.

Authors:  H Corrodi; K Fuxe; T Hökfelt; P Lidbrink; U Ungerstedt
Journal:  J Pharm Pharmacol       Date:  1973-05       Impact factor: 3.765

9.  Comparative effects of apomorphine, piribedil and other neurotropic agents on central analgesic-induced catatonia in the rat.

Authors:  J C Poignant; H Gressier; E Malecot
Journal:  Eur J Pharmacol       Date:  1974-11       Impact factor: 4.432

10.  Dopamine agonist and antagonist activities of piribedil (ET495)and its metabolites.

Authors:  B Costall; R J Naylor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.